LEF1 anticorps (N-Term)
Aperçu rapide pour LEF1 anticorps (N-Term) (ABIN2299290)
Antigène
Voir toutes LEF1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 17-45, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- LEF1, NT (LEF1, Lymphoid enhancer-binding factor 1, T cell-specific transcription factor 1-alpha)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- LEF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 17-45 amino acids from the N-terminal region of human LEF1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
-
Autre désignation
- LEF1
-
NCBI Accession
- NP_057353
-
UniProt
- Q9UJU2
-
Pathways
- Signalisation WNT, Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Hormone Metabolic Process, Nuclear Hormone Receptor Binding, Chromatin Binding
Antigène
-